Advanced glycation end products: Keyplayers in skin aging?

Dermato-Endocrinology

Volumn 4, Issue 3, 2012, Pages

  Gkogkolou, Paraskevi ^a   Böhm, Markus ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Advanced glycation end products; AGEs; Photoaging; RAGE; Skin aging

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; CARBOXYMETHYL LYSINE; CELL PROTEIN; FRUCTOSYL AMINE OXIDASE; GLUTATHIONE; LYSINE; MITOGEN ACTIVATED PROTEIN KINASE; OXIDOREDUCTASE; PENTOSIDINE; PYRIDOXAMINE; SCLEROPROTEIN; UNCLASSIFIED DRUG;

AGING; BIOCHEMISTRY; CALORIC RESTRICTION; CUTANEOUS PARAMETERS; GLYCATION; HUMAN; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; REVIEW; SKIN CELL;

EID: 84871912190     PISSN: 19381972     EISSN: 19381980     Source Type: Journal    
DOI: 10.4161/derm.22028     Document Type: Review

References (150)

1. Viña J, Borrás C, Miquel J. Theories of ageing. IUBMB Life 2007; 59:249-54; PMID:17505961; http://dx.doi.org/10.1080/15216540601178067.
2. Zouboulis CC, Makrantonaki E. Clinical aspects and molecular diagnostics of skin aging. Clin Dermatol 2011; 29:3-14; PMID:21146726; http://dx.doi.org/10. 1016/j.clindermatol.2010.07.001.
3. Makrantonaki E, Zouboulis CC. William J. Cunliffe Scientific Awards. Characteristics and pathomechanisms of endogenously aged skin. Dermatology 2007; 214:352-60; PMID:17460411; http://dx.doi.org/10.1159/000100890.
4. Makrantonaki E, Zouboulis CC. Molecular mechanisms of skin aging: state of the art. Ann N Y Acad Sci 2007; 1119:40-50; PMID:18056953; http://dx.doi.org/10.1196/annals.1404.027.
5. Fisher GJ, Kang S, Varani J, Bata-Csorgo Z, Wan Y, Datta S, et al. Mechanisms of photoaging and chronological skin aging. Arch Dermatol 2002; 138:1462-70; PMID:12437452; http://dx.doi.org/10.1001/archderm.138.11.1462.
6. Bernhard D, Moser C, Backovic A, Wick G. Cigarette smoke - an aging accelerator? Exp Gerontol 2007; 42:160-5; PMID:17084574; http://dx.doi.org/10. 1016/j.exger.2006.09.016.
7. Medvedev ZA. An attempt at a rational classification of theories of ageing. Biol Rev Camb Philos Soc 1990; 65:375-98; PMID:2205304; http://dx.doi.org/10.1111/j.1469-185X.1990.tb01428.x.
8. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 1995; 92:9363-7; PMID:7568133; http://dx.doi.org/10.1073/pnas.92.20.9363.
9. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A 1992; 89:10114-8; PMID:1438199; http://dx.doi.org/10.1073/ pnas.89.21.10114.
10. Michikawa Y, Mazzucchelli F, Bresolin N, Scarlato G, Attardi G. Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science 1999; 286:774-9; PMID:10531063; http://dx.doi.org/10.1126/science.286.5440.774.
11. Harman D. The free radical theory of aging. Antioxid Redox Signal 2003; 5:557-61; PMID:14580310; http://dx.doi.org/10.1089/152308603770310202.
12. Giacomoni PU, Rein G. Factors of skin ageing share common mechanisms. Biogerontology 2001; 2:219-29; PMID:11868897; http://dx.doi.org/10.1023/A: 1013222629919.
13. Ahmed N. Advanced glycation endproducts - role in pathology of diabetic complications. Diabetes Res Clin Pract 2005; 67:3-21; PMID:15620429; http://dx.doi.org/10.1016/j.diabres.2004.09.004.
14. Maillard LC. Action des acides amines sur les sucres: formation des melanoidines par voie methodique. C R Acad Sci (Paris) 1912; 154:66-8.
15. Hodge JE. Dehydrated foods, chemistry of browning reactions in model systems. J Agric Food Chem 1953; 1:928-43; http://dx.doi.org/10.1021/ jf60015a004.
16. Paul RG, Bailey AJ. Glycation of collagen: the basis of its central role in the late complications of ageing and diabetes. Int J Biochem Cell Biol 1996; 28:1297-310; PMID:9022289; http://dx.doi.org/10.1016/S1357-2725(96)00079-9.
17. Thorpe SR, Baynes JW. Maillard reaction products in tissue proteins: new products and new perspectives. Amino Acids 2003; 25:275-81; PMID:14661090; http://dx.doi.org/10.1007/s00726-003-0017-9.
18. Kawabata K, Yoshikawa H, Saruwatari K, Akazawa Y, Inoue T, Kuze T, et al. The presence of N(ε)-(Carboxymethyl) lysine in the human epidermis. Biochim Biophys Acta 2011; 1814:1246-52; PMID:21708295; http://dx.doi.org/10. 1016/j.bbapap.2011.06.006.
19. Dyer DG, Dunn JA, Thorpe SR, Bailie KE, Lyons TJ, McCance DR, et al. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 1993; 91:2463-9; PMID:8514858; http://dx.doi.org/10.1172/ JCI116481.
20. Jeanmaire C, Danoux L, Pauly G. Glycation during human dermal intrinsic and actinic ageing: an in vivo and in vitro model study. Br J Dermatol 2001; 145:10-8; PMID:11453901; http://dx.doi.org/10.1046/j.1365-2133.2001.04275.x.
21. Fan X, Sell DR, Zhang J, Nemet I, Theves M, Lu J, et al. Anaerobic vs aerobic pathways of carbonyl and oxidant stress in human lens and skin during aging and in diabetes: A comparative analysis. Free Radic Biol Med 2010; 49:847-56; PMID:20541005; http://dx.doi.org/10.1016/j.freeradbiomed.2010.06.003.
22. Kueper T, Grune T, Prahl S, Lenz H, Welge V, Biernoth T, et al. Vimentin is the specific target in skin glycation. Structural prerequisites, functional consequences, and role in skin aging. J Biol Chem 2007; 282:23427-36; PMID:17567584; http://dx.doi.org/10.1074/jbc.M701586200.
23. Mizutari K, Ono T, Ikeda K, Kayashima K, Horiuchi S. Photo-enhanced modification of human skin elastin in actinic elastosis by N(epsilon)- (carboxymethyl)lysine, one of the glycoxidation products of the Maillard reaction. J Invest Dermatol 1997; 108:797-802; PMID:9129235; http://dx.doi.org/10.1111/1523-1747.ep12292244.
24. Yu Y, Thorpe SR, Jenkins AJ, Shaw JN, Sochaski MA, McGee D, et al.; DCCT/EDIC Research Group. Advanced glycation end-products and methionine sulphoxide in skin collagen of patients with type 1 diabetes. Diabetologia 2006; 49:2488-98; PMID:16955213; http://dx.doi.org/10.1007/s00125-006-0355-8.
25. Taneda S, Monnier VM. ELISA of pentosidine, an advanced glycation end product, in biological specimens. Clin Chem 1994; 40:1766-73; PMID:8070089.
26. Sell DR, Biemel KM, Reihl O, Lederer MO, Strauch CM, Monnier VM. Glucosepane is a major protein cross-link of the senescent human extracellular matrix. Relationship with diabetes. J Biol Chem 2005; 280:12310-5; PMID:15677467; http://dx.doi.org/10.1074/jbc.M500733200.
27. Ahmed MU, Brinkmann Frye E, Degenhardt TP, Thorpe SR, Baynes JW. N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J 1997; 324:565-70; PMID:9182719.
28. Frye EB, Degenhardt TP, Thorpe SR, Baynes JW. Role of the Maillard reaction in aging of tissue proteins. Advanced glycation end product-dependent increase in imidazolium cross-links in human lens proteins. J Biol Chem 1998; 273:18714-9; PMID:9668043; http:// dx.doi.org/10.1074/jbc.273.30.18714.
29. Ahmed MU, Thorpe SR, Baynes JW. Identification of N epsilon- carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem 1986; 261:4889-94; PMID:3082871.
30. Reddy S, Bichler J, Wells-Knecht KJ, Thorpe SR, Baynes JW. N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry 1995; 34:10872-8; PMID:7662668; http://dx.doi.org/10.1021/bi00034a021.
31. Sell DR, Monnier VM. Isolation, purification and partial characterization of novel fluorophores from aging human insoluble collagen-rich tissue. Connect Tissue Res 1989; 19:77-92; PMID:2791558; http://dx.doi.org/10.3109/ 03008208909016816.
32. Thornalley PJ, Langborg A, Minhas HS. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J 1999; 344:109-16; PMID:10548540; http://dx.doi.org/10.1042/0264-6021:3440109.
33. Fleming TH, Humpert PM, Nawroth PP, Bierhaus A. Reactive metabolites and AGE/RAGE-mediated cellular dysfunction affect the aging process: a mini-review. Gerontology 2011; 57:435-43; PMID:20962515.
34. Cerami C, Founds H, Nicholl I, Mitsuhashi T, Giordano D, Vanpatten S, et al. Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci U S A 1997; 94:13915-20; PMID:9391127; http://dx.doi.org/10.1073/pnas. 94.25.13915.
35. Leslie RD, Beyan H, Sawtell P, Boehm BO, Spector TD, Snieder H. Level of an advanced glycated end product is genetically determined: a study of normal twins. Diabetes 2003; 52:2441-4; PMID:12941787; http://dx.doi.org/10.2337/ diabetes.52.9.2441.
36. Thornalley PJ. The enzymatic defence against glycation in health, disease and therapeutics: a symposium to examine the concept. Biochem Soc Trans 2003; 31:1341-2; PMID:14641059; http://dx.doi.org/10.1042/BST0311341.
37. Xue M, Rabbani N, Thornalley PJ. Glyoxalase in ageing. Semin Cell Dev Biol 2011; 22:293-301; PMID:21320620; http://dx.doi.org/10.1016/j.semcdb.2011. 02.013.
38. Wu X, Monnier VM. Enzymatic deglycation of proteins. Arch Biochem Biophys 2003; 419:16-24; PMID:14568004; http://dx.doi.org/10.1016/j.abb.2003.08.011.
39. Van Schaftingen E, Collard F, Wiame E, Veigada-Cunha M. Enzymatic repair of Amadori products. Amino Acids 2012; 42:1143-50; PMID:20967558; http://dx.doi.org/10.1007/s00726-010-0780-3.
40. Conner JR, Beisswenger PJ, Szwergold BS. Some clues as to the regulation, expression, function, and distribution of fructosamine-3-kinase and fructosamine-3-kinase-related protein. Ann N Y Acad Sci 2005; 1043:824-36; PMID:16037310; http://dx.doi.org/10.1196/annals.1333.095.
41. Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, Arnold B, et al. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med (Berl) 2005; 83:876-86; PMID:16133426; http://dx.doi.org/10.1007/s00109-005- 0688-7.
42. Miyata T, Inagi R, Iida Y, Sato M, Yamada N, Oda O, et al. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1. J Clin Invest 1994; 93:521-8; PMID:8113390; http://dx.doi.org/10. 1172/JCI117002.
43. Loughlin DT, Artlett CM. Precursor of advanced glycation end products mediates ER-stress-induced caspase-3 activation of human dermal fibroblasts through NAD(P)H oxidase 4. PLoS One 2010; 5:e11093; PMID:20559423; http://dx.doi.org/10.1371/journal.pone.0011093.
44. Ramasamy R, Vannucci SJ, Yan SS, Herold K, Yan SF, Schmidt AM. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 2005; 15:16R-28R; PMID:15764591; http://dx.doi.org/10.1093/glycob/cwi053.
45. Lohwasser C, Neureiter D, Weigle B, Kirchner T, Schuppan D. The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha. J Invest Dermatol 2006; 126:291-9; PMID:16374460; http://dx.doi.org/10.1038/sj. jid.5700070.
46. Fujimoto E, Kobayashi T, Fujimoto N, Akiyama M, Tajima S, Nagai R. AGE-modified collagens I and III induce keratinocyte terminal differentiation through AGE receptor CD36: epidermal-dermal interaction in acquired perforating dermatosis. J Invest Dermatol 2010; 130:405-14; PMID:19865095; http://dx.doi.org/10.1038/jid.2009.269.
47. Zhu P, Ren M, Yang C, Hu YX, Ran JM, Yan L. Involvement of RAGE, MAPK and NF-κB pathways in AGEs-induced MMP-9 activation in HaCaT keratinocytes. Exp Dermatol 2012; 21:123-9; PMID:22229442; http://dx.doi.org/10.1111/j.1600- 0625.2011.01408.x.
48. Schmidt AM, Yan SD, Brett J, Mora R, Nowygrod R, Stern D. Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. J Clin Invest 1993; 91:2155-68; PMID:8387541; http://dx.doi.org/10.1172/JCI116442.
49. Hilmenyuk T, Bellinghausen I, Heydenreich B, Ilchmann A, Toda M, Grabbe S, et al. Effects of glycation of the model food allergen ovalbumin on antigen uptake and presentation by human dendritic cells. Immunology 2010; 129:437-45; PMID:19922418; http://dx.doi.org/10.1111/j.1365-2567.2009.03199.x.
50. Chen Y, Akirav EM, Chen W, Henegariu O, Moser B, Desai D, et al. RAGE ligation affects T cell activation and controls T cell differentiation. J Immunol 2008; 181:4272-8; PMID:18768885.
51. Tanaka N, Yonekura H, Yamagishi S, Fujimori H, Yamamoto Y, Yamamoto H. The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells. J Biol Chem 2000; 275:25781-90; PMID:10829018; http://dx.doi.org/10.1074/jbc. M001235200.
52. Vlassara H. The AGE-receptor in the pathogenesis of diabetic complications. Diabetes Metab Res Rev 2001; 17:436-43; PMID:11757079; http://dx.doi.org/10.1002/dmrr.233.
53. Lu C, He JC, Cai W, Liu H, Zhu L, Vlassara H. Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells. Proc Natl Acad Sci U S A 2004; 101:11767-72; PMID:15289604; http://dx.doi.org/10.1073/pnas.0401588101.
54. Cai W, He JC, Zhu L, Chen X, Zheng F, Striker GE, et al. Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan. Am J Pathol 2008; 173:327-36; PMID:18599606; http://dx.doi.org/10.2353/ajpath.2008.080152.
55. Ramasamy R, Yan SF, Schmidt AM. RAGE: therapeutic target and biomarker of the inflammatory response - the evidence mounts. J Leukoc Biol 2009; 86:505-12; PMID:19477910; http://dx.doi.org/10.1189/jlb.0409230.
56. Verzijl N, DeGroot J, Oldehinkel E, Bank RA, Thorpe SR, Baynes JW, et al. Age-related accumulation of Maillard reaction products in human articular cartilage collagen. Biochem J 2000; 350:381-7; PMID:10947951; http://dx.doi.org/10.1042/0264-6021:3500381.
57. Haus JM, Carrithers JA, Trappe SW, Trappe TA. Collagen, cross-linking, and advanced glycation end products in aging human skeletal muscle. J Appl Physiol 2007; 103:2068-76; PMID:17901242; http://dx.doi.org/10.1152/ japplphysiol.00670.2007.
58. Sell DR, Carlson EC, Monnier VM. Differential effects of type 2 (non-insulin-dependent) diabetes mellitus on pentosidine formation in skin and glomerular basement membrane. Diabetologia 1993; 36:936-41; PMID:8243873; http://dx.doi.org/10.1007/BF02374476.
59. Vlassara H, Cai W, Crandall J, Goldberg T, Oberstein R, Dardaine V, et al. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci U S A 2002; 99:15596-601; PMID:12429856; http://dx.doi.org/10.1073/pnas.242407999.
60. Glenn JV, Beattie JR, Barrett L, Frizzell N, Thorpe SR, Boulton ME, et al. Confocal Raman microscopy can quantify advanced glycation end product (AGE) modifications in Bruch's membrane leading to accurate, nondestructive prediction of ocular aging. FASEB J 2007; 21:3542-52; PMID:17567569; http://dx.doi.org/10. 1096/fj.06-7896com.
61. Stitt AW. Advanced glycation: an important pathological event in diabetic and age related ocular disease. Br J Ophthalmol 2001; 85:746-53; PMID:11371498; http://dx.doi.org/10.1136/bjo.85.6.746.
62. DeGroot J, Verzijl N, Wenting-Van Wijk MJ, Bank RA, Lafeber FP, Bijlsma JW, et al. Age-related decrease in susceptibility of human articular cartilage to matrix metalloproteinase-mediated degradation: the role of advanced glycation end products. Arthritis Rheum 2001; 44:2562-71; PMID:11710713; http://dx.doi.org/10.1002/1529-0131(200111)44:11〈2562::AIDART437〉3.0. CO;2-1.
63. Sell DR, Lane MA, Johnson WA, Masoro EJ, Mock OB, Reiser KM, et al. Longevity and the genetic determination of collagen glycoxidation kinetics in mammalian senescence. Proc Natl Acad Sci U S A 1996; 93:485-90; PMID:8552666; http://dx.doi.org/10.1073/pnas.93.1.485.
64. Schleicher ED, Wagner E, Nerlich AG. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest 1997; 99:457-68; PMID:9022079; http://dx.doi.org/10.1172/JCI119180.
65. Corstjens H, Dicanio D, Muizzuddin N, Neven A, Sparacio R, Declercq L, et al. Glycation associated skin autofluorescence and skin elasticity are related to chronological age and body mass index of healthy subjects. Exp Gerontol 2008; 43:663-7; PMID:18334287; http://dx.doi.org/10.1016/j.exger.2008.01.012.
66. Verzijl N, DeGroot J, Thorpe SR, Bank RA, Shaw JN, Lyons TJ, et al. Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem 2000; 275:39027-31; PMID:10976109; http://dx.doi.org/10. 1074/jbc.M006700200.
67. Dunn JA, McCance DR, Thorpe SR, Lyons TJ, Baynes JW. Age-dependent accumulation of N epsilon-(carboxymethyl)lysine and N epsilon-(carboxymethyl) hydroxylysine in human skin collagen. Biochemistry 1991; 30:1205-10; PMID:1899338; http://dx.doi.org/10.1021/bi00219a007.
68. Pageon H. Reaction of glycation and human skin: the effects on the skin and its components, reconstructed skin as a model. Pathol Biol (Paris) 2010; 58:226-31; PMID:19896301; http://dx.doi.org/10.1016/j.patbio.2009.09.009.
69. Yamauchi M, Prisayanh P, Haque Z, Woodley DT. Collagen cross-linking in sun-exposed and unexposed sites of aged human skin. J Invest Dermatol 1991; 97:938-41; PMID:1919057; http://dx.doi.org/10.1111/1523-1747.ep12491727.
70. Nicholl ID, Stitt AW, Moore JE, Ritchie AJ, Archer DB, Bucala R. Increased levels of advanced glycation endproducts in the lenses and blood vessels of cigarette smokers. Mol Med 1998; 4:594-601; PMID:9848076.
71. Lutgers HL, Graaff R, Links TP, Ubink-Veltmaat LJ, Bilo HJ, Gans RO, et al. Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes. Diabetes Care 2006; 29:2654-9; PMID:17130200; http://dx.doi.org/10.2337/dc05-2173.
72. Goldberg T, Cai W, Peppa M, Dardaine V, Baliga BS, Uribarri J, et al. Advanced glycoxidation end products in commonly consumed foods. J Am Diet Assoc 2004; 104:1287-91; PMID:15281050; http://dx.doi.org/10.1016/j.jada.2004.05.214.
73. Uribarri J, Cai W, Peppa M, Goodman S, Ferrucci L, Striker G, et al. Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J Gerontol A Biol Sci Med Sci 2007; 62:427-33; PMID:17452738; http://dx.doi.org/10.1093/gerona/62.4.427.
74. Avery NC, Bailey AJ. The effects of the Maillard reaction on the physical properties and cell interactions of collagen. Pathol Biol (Paris) 2006; 54:387-95; PMID:16962252; http://dx.doi.org/10.1016/j.patbio.2006.07.005.
75. Haitoglou CS, Tsilibary EC, Brownlee M, Charonis AS. Altered cellular interactions between endothelial cells and nonenzymatically glucosylated laminin/type IV collagen. J Biol Chem 1992; 267:12404-7; PMID:1618745.
76. DeGroot J. The AGE of the matrix: chemistry, consequence and cure. Curr Opin Pharmacol 2004; 4:301-5; PMID:15140424; http://dx.doi.org/10.1016/j.coph. 2004.01.007.
77. Yoshinaga E, Kawada A, Ono K, Fujimoto E, Wachi H, Harumiya S, et al. N(å)-(carboxymethyl)lysine modification of elastin alters its biological properties: implications for the accumulation of abnormal elastic fibers in actinic elastosis. J Invest Dermatol 2012; 132:315-23; PMID:21956123; http://dx.doi.org/10.1038/jid.2011.298.
78. Reihsner R, Melling M, Pfeiler W, Menzel EJ. Alterations of biochemical and two-dimensional biomechanical properties of human skin in diabetes mellitus as compared to effects of in vitro non-enzymatic glycation. Clin Biomech (Bristol, Avon) 2000; 15:379-86; PMID:10758300; http://dx.doi.org/10.1016/S0268- 0033(99)00085-6.
79. Yoon HS, Baik SH, Oh CH. Quantitative measurement of desquamation and skin elasticity in diabetic patients. Skin Res Technol 2002; 8:250-4; PMID:12423544; http://dx.doi.org/10.1034/j.1600-0846.2002.00332.x.
80. Giardino I, Edelstein D, Brownlee M. Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes. J Clin Invest 1994; 94:110-7; PMID:8040253; http://dx.doi.org/10.1172/JCI117296.
81. Uchiki T, Weikel KA, Jiao W, Shang F, Caceres A, Pawlak D, et al. Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in nondiabetics). Aging Cell 2012; 11:1-13; PMID:21967227; http://dx.doi.org/10.1111/j.1474-9726.2011.00752. x.
82. Ukeda H, Hasegawa Y, Ishi T, Sawamura M. Inactivation of Cu,Zn-superoxide dismutase by intermediates of Maillard reaction and glycolytic pathway and some sugars. Biosci Biotechnol Biochem 1997; 61:2039-42; PMID:9438984; http://dx.doi.org/10.1271/bbb.61.2039.
83. Baynes JW. The Maillard hypothesis on aging: time to focus on DNA. Ann N Y Acad Sci 2002; 959:360-7; PMID:11976210; http://dx.doi.org/10.1111/j.1749- 6632.2002.tb02107.x.
84. Zhu P, Yang C, Chen LH, Ren M, Lao GJ, Yan L. Impairment of human keratinocyte mobility and proliferation by advanced glycation end products-modified BSA. Arch Dermatol Res 2011; 303:339-50; PMID:21132435; http://dx.doi.org/10.1007/s00403-010-1102-z.
85. Wondrak GT, Roberts MJ, Jacobson MK, Jacobson EL. Photosensitized growth inhibition of cultured human skin cells: mechanism and suppression of oxidative stress from solar irradiation of glycated proteins. J Invest Dermatol 2002; 119:489-98; PMID:12190875; http://dx.doi.org/10.1046/j.1523-1747.2002.01788.x.
86. Berge U, Behrens J, Rattan SI. Sugar-induced premature aging and altered differentiation in human epidermal keratinocytes. Ann N Y Acad Sci 2007; 1100:524-9; PMID:17460218; http://dx.doi.org/10.1196/annals.1395.058.
87. Alikhani Z, Alikhani M, Boyd CM, Nagao K, Trackman PC, Graves DT. Advanced glycation end products enhance expression of pro-apoptotic genes and stimulate fibroblast apoptosis through cytoplasmic and mitochondrial pathways. J Biol Chem 2005; 280:12087-95; PMID:15590648; http://dx.doi.org/10.1074/jbc. M406313200.
88. Molinari J, Ruszova E, Velebny V, Robert L. Effect of advanced glycation endproducts on gene expression profiles of human dermal fibroblasts. Biogerontology 2008; 9:177-82; PMID:18297408; http://dx.doi.org/10.1007/s10522- 008-9129-7.
89. Ravelojaona V, Robert AM, Robert L. Expression of senescence-associated beta-galactosidase (SA-beta-Gal) by human skin fibroblasts, effect of advanced glycation end-products and fucose or rhamnose-rich polysaccharides. Arch Gerontol Geriatr 2009; 48:151-4; PMID:18207583; http://dx.doi.org/10.1016/j. archger.2007.12.004.
90. Sejersen H, Rattan SI. Dicarbonyl-induced accelerated aging in vitro in human skin fibroblasts. Biogerontology 2009; 10:203-11; PMID:18758988; http://dx.doi.org/10.1007/s10522-008-9172-4.
91. Schmidt AM, Hori O, Chen J, Li JF, Crandall J, Zhang J, et al. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1): a potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 1995; 96:1395-403; PMID:7544803; http://dx.doi.org/10.1172/JCI118175.
92. Portero-Otín M, Pamplona R, Bellmunt MJ, Ruiz MC, Prat J, Salvayre R, et al. Advanced glycation end product precursors impair epidermal growth factor receptor signaling. Diabetes 2002; 51:1535-42; PMID:11978653; http://dx.doi.org/10.2337/diabetes.51.5.1535.
93. Masaki H, Okano Y, Sakurai H. Generation of active oxygen species from advanced glycation end-products (AGE) under ultraviolet light A (UVA) irradiation. Biochem Biophys Res Commun 1997; 235:306-10; PMID:9199187; http://dx.doi.org/10.1006/bbrc.1997.6780.
94. Yim MB, Yim HS, Lee C, Kang SO, Chock PB. Protein glycation: creation of catalytic sites for free radical generation. Ann N Y Acad Sci 2001; 928:48-53; PMID:11795527; http://dx.doi.org/10.1111/j.1749-6632.2001.tb05634.x.
95. Lee C, Yim MB, Chock PB, Yim HS, Kang SO. Oxidation-reduction properties of methylglyoxal-modified protein in relation to free radical generation. J Biol Chem 1998; 273:25272-8; PMID:9737992; http://dx.doi.org/10.1074/jbc.273.39. 25272.
96. Qian M, Liu M, Eaton JW. Transition metals bind to glycated proteins forming redox active "glycochelates": implications for the pathogenesis of certain diabetic complications. Biochem Biophys Res Commun 1998; 250:385-9; PMID:9753639; http://dx.doi.org/10.1006/bbrc.1998.9326.
97. Wondrak GT. Let the sun shine in: mechanisms and potential for therapeutics in skin photodamage. Curr Opin Investig Drugs 2007; 8:390-400; PMID:17520868.
98. Meerwaldt R, Links T, Graaff R, Thorpe SR, Baynes JW, Hartog J, et al. Simple noninvasive measurement of skin autofluorescence. Ann N Y Acad Sci 2005; 1043:290-8; PMID:16037251; http://dx.doi.org/10.1196/annals.1333.036.
99. Mulder DJ, Water TV, Lutgers HL, Graaff R, Gans RO, Zijlstra F, et al. Skin autofluorescence, a novel marker for glycemic and oxidative stress-derived advanced glycation endproducts: an overview of current clinical studies, evidence, and limitations. Diabetes Technol Ther 2006; 8:523-35; PMID:17037967; http://dx.doi.org/10.1089/dia.2006.8.523.
100. Tseng JY, Ghazaryan AA, Lo W, Chen YF, Hovhannisyan V, Chen SJ, et al. Multiphoton spectral microscopy for imaging and quantification of tissue glycation. Biomed Opt Express 2010; 2:218-30; PMID:21339868; http://dx.doi.org/10.1364/BOE.2.000218.
101. Bos DC, de Ranitz-Greven WL, de Valk HW. Advanced glycation end products, measured as skin autofluorescence and diabetes complications: a systematic review. Diabetes Technol Ther 2011; 13:773-9; PMID:21510765; http://dx.doi.org/10.1089/dia.2011.0034.
102. Smit AJ, Gerrits EG. Skin autofluorescence as a measure of advanced glycation endproduct deposition: a novel risk marker in chronic kidney disease. Curr Opin Nephrol Hypertens 2010; 19:527-33; PMID:20844429; http://dx.doi.org/ 10.1097/MNH.0b013e32833e9259.
103. Genuth S, Sun W, Cleary P, Sell DR, Dahms W, Malone J, et al.; DCCT Skin Collagen Ancillary Study Group. Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes. Diabetes 2005; 54:3103-11; PMID:16249432; http://dx.doi.org/10.2337/ diabetes.54.11.3103.
104. Beisswenger PJ, Howell S, Mackenzie T, Corstjens H, Muizzuddin N, Matsui MS. Two fluorescent wavelengths, 440(ex)/520(em) nm and 370(ex)/440(em) nm, reflect advanced glycation and oxidation end products in human skin without diabetes. Diabetes Technol Ther 2012; 14:285-92; PMID:22023375; http://dx.doi.org/10.1089/dia.2011.0108.
105. Farris PK. Innovative cosmeceuticals: sirtuin activators and anti-glycation compounds. Semin Cutan Med Surg 2011; 30:163-6; PMID:21925370; http://dx.doi.org/10.1016/j.sder.2011.05.004.
106. Elosta A, Ghous T, Ahmed N. Natural products as anti-glycation agents: possible therapeutic potential for diabetic complications. Curr Diabetes Rev 2012; 8:92-108; PMID:22268395; http://dx.doi.org/10.2174/157339912799424528.
107. Edelstein D, Brownlee M. Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes 1992; 41:26-9; PMID:1727735; http://dx.doi.org/10.2337/diabetes.41.1.26.
108. Reddy VP, Beyaz A. Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases. Drug Discov Today 2006; 11:646-54; PMID:16793534; http://dx.doi.org/10.1016/j.drudis.2006.05.016.
109. Pageon H, Técher MP, Asselineau D. Reconstructed skin modified by glycation of the dermal equivalent as a model for skin aging and its potential use to evaluate anti-glycation molecules. Exp Gerontol 2008; 43:584-8; PMID:18485649; http://dx.doi.org/10.1016/j.exger.2008.04.004.
110. Sell DR, Nelson JF, Monnier VM. Effect of chronic aminoguanidine treatment on age-related glycation, glycoxidation, and collagen cross-linking in the Fischer 344 rat. J Gerontol A Biol Sci Med Sci 2001; 56:B405-11; PMID:11524442; http://dx.doi.org/10.1093/gerona/56.9.B405.
111. Degenhardt TP, Alderson NL, Arrington DD, Beattie RJ, Basgen JM, Steffes MW, et al. Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat. Kidney Int 2002; 61:939-50; PMID:11849448; http://dx.doi.org/10.1046/j.1523-1755.2002.00207.x.
112. Voziyan PA, Hudson BG. Pyridoxamine: the many virtues of a maillard reaction inhibitor. Ann N Y Acad Sci 2005; 1043:807-16; PMID:16037308; http://dx.doi.org/10.1196/annals.1333.093.
113. Vasan S, Foiles P, Founds H. Therapeutic potential of breakers of advanced glycation end product-protein crosslinks. Arch Biochem Biophys 2003; 419:89-96; PMID:14568012; http://dx.doi.org/10.1016/j.abb.2003.08.016.
114. Candido R, Forbes JM, Thomas MC, Thallas V, Dean RG, Burns WC, et al. A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes. Circ Res 2003; 92:785-92; PMID:12623881; http://dx.doi.org/10.1161/01.RES.0000065620.39919.20.
115. Bakris GL, Bank AJ, Kass DA, Neutel JM, Preston RA, Oparil S. Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process. Am J Hypertens 2004; 17:23S-30S; PMID:15607432; http://dx.doi.org/10.1016/j.amjhyper.2004.08.022.
116. Yang S, Litchfield JE, Baynes JW. AGE-breakers cleave model compounds, but do not break Maillard crosslinks in skin and tail collagen from diabetic rats. Arch Biochem Biophys 2003; 412:42-6; PMID:12646266; http://dx.doi.org/10. 1016/S0003-9861(03)00015-8.
117. Monnier VM, Sell DR. Prevention and repair of protein damage by the Maillard reaction in vivo. Rejuvenation Res 2006; 9:264-73; PMID:16706654; http://dx.doi.org/10.1089/rej.2006.9.264.
118. Monnier VM, Wu X. Enzymatic deglycation with amadoriase enzymes from Aspergillus sp. as a potential strategy against the complications of diabetes and aging. Biochem Soc Trans 2003; 31:1349-53; PMID:14641061; http://dx.doi.org/10.1042/BST0311349.
119. Shinohara M, Thornalley PJ, Giardino I, Beisswenger P, Thorpe SR, Onorato J, et al. Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J Clin Invest 1998; 101:1142-7; PMID:9486985; http://dx.doi.org/10.1172/JCI119885.
120. Kim KM, Kim YS, Jung DH, Lee J, Kim JS. Increased glyoxalase I levels inhibit accumulation of oxidative stress and an advanced glycation end product in mouse mesangial cells cultured in high glucose. Exp Cell Res 2012; 318:152-9; PMID:22036650; http://dx.doi.org/10.1016/j.yexcr.2011.10.013.
121. Brouwers O, Niessen PM, Ferreira I, Miyata T, Scheffer PG, Teerlink T, et al. Overexpression of glyoxalase-I reduces hyperglycemia-induced levels of advanced glycation end products and oxidative stress in diabetic rats. J Biol Chem 2011; 286:1374-80; PMID:21056979; http://dx.doi.org/10.1074/jbc.M110. 144097.
122. Xue M, Rabbani N, Momiji H, Imbasi P, Anwar MM, Kitteringham N, et al. Transcriptional control of glyoxalase 1 by Nrf2 provides a stress-responsive defence against dicarbonyl glycation. Biochem J 2012; 443:213-22; PMID:22188542; http://dx.doi.org/10.1042/BJ20111648.
123. Price DL, Rhett PM, Thorpe SR, Baynes JW. Chelating activity of advanced glycation end-product inhibitors. J Biol Chem 2001; 276:48967-72; PMID:11677237; http://dx.doi.org/10.1074/jbc.M108196200.
124. Rutter K, Sell DR, Fraser N, Obrenovich M, Zito M, Starke-Reed P, et al. Green tea extract suppresses the age-related increase in collagen crosslinking and fluorescent products in C57BL/6 mice. Int J Vitam Nutr Res 2003; 73:453-60; PMID:14743550; http://dx.doi.org/10.1024/0300-9831.73.6.453.
125. Tarwadi KV, Agte VV. Effect of micronutrients on methylglyoxal-mediated in vitro glycation of albumin. Biol Trace Elem Res 2011; 143:717-25; PMID:21165710; http://dx.doi.org/10.1007/s12011-010-8915-7.
126. Thirunavukkarasu V, Nandhini AT, Anuradha CV. Lipoic acid prevents collagen abnormalities in tail tendon of high-fructose-fed rats. Diabetes Obes Metab 2005; 7:294-7; PMID:15811148; http://dx.doi.org/10.1111/j.1463-1326.2004. 00418.x.
127. Odetti P, Pesce C, Traverso N, Menini S, Maineri EP, Cosso L, et al. Comparative trial of N-acetylcysteine, taurine, and oxerutin on skin and kidney damage in long-term experimental diabetes. Diabetes 2003; 52:499-505; PMID:12540627; http://dx.doi.org/10.2337/diabetes.52.2.499.
128. Rasheed Z, Anbazhagan AN, Akhtar N, Ramamurthy S, Voss FR, Haqqi TM. Green tea polyphenol epigallocatechin-3-gallate inhibits advanced glycation end product-induced expression of tumor necrosis factor-alpha and matrix metalloproteinase-13 in human chondrocytes. Arthritis Res Ther 2009; 11:R71; PMID:19445683; http://dx.doi.org/10.1186/ar2700.
129. Vinson JA, Howard HB. Inhibition of protein glycation and advanced glycation end products by ascorbic acid and other vitamins and nutrients. J Nutr Biochem 1996; 7:659-63; http://dx.doi.org/10.1016/S0955-2863(96)00128-3.
130. Dearlove RP, Greenspan P, Hartle DK, Swanson RB, Hargrove JL. Inhibition of protein glycation by extracts of culinary herbs and spices. J Med Food 2008; 11:275-81; PMID:18598169; http://dx.doi.org/10.1089/jmf.2007.536.
131. Jin S, Cho KH. Water extracts of cinnamon and clove exhibits potent inhibition of protein glycation and anti-atherosclerotic activity in vitro and in vivo hypolipidemic activity in zebrafish. Food Chem Toxicol 2011; 49:1521-9; PMID:21443916; http://dx.doi.org/10.1016/j.fct.2011.03.043.
132. Draelos ZD, Yatskayer M, Raab S, Oresajo C. An evaluation of the effect of a topical product containing C-xyloside and blueberry extract on the appearance of type II diabetic skin. J Cosmet Dermatol 2009; 8:147-51; PMID:19527341; http://dx.doi.org/10.1111/j.1473-2165.2009.00428.x.
133. Wu CH, Yen GC. Inhibitory effect of naturally occurring flavonoids on the formation of advanced glycation endproducts. J Agric Food Chem 2005; 53:3167-73; PMID:15826074; http://dx.doi.org/10.1021/jf048550u.
134. Lee CK, Klopp RG, Weindruch R, Prolla TA. Gene expression profile of aging and its retardation by caloric restriction. Science 1999; 285:1390-3; PMID:10464095; http://dx.doi.org/10.1126/science.285.5432.1390.
135. Cefalu WT, Bell-Farrow AD, Wang ZQ, Sonntag WE, Fu MX, Baynes JW, et al. Caloric restriction decreases age-dependent accumulation of the glycoxidation products, N epsilon-(carboxymethyl)lysine and pentosidine, in rat skin collagen. J Gerontol A Biol Sci Med Sci 1995; 50:B337-41; PMID:7583789; http://dx.doi.org/10.1093/gerona/50A.6.B337.
136. Reiser KM. Influence of age and long-term dietary restriction on enzymatically mediated crosslinks and nonenzymatic glycation of collagen in mice. J Gerontol 1994; 49:B71-9; PMID:8126349.
137. Sell DR, Kleinman NR, Monnier VM. Longitudinal determination of skin collagen glycation and glycoxidation rates predicts early death in C57BL/6NNIA mice. FASEB J 2000; 14:145-56; PMID:10627289.
138. Vlassara H, Uribarri J, Ferrucci L, Cai W, Torreggiani M, Post JB, et al. Identifying advanced glycation end products as a major source of oxidants in aging: implications for the management and/or prevention of reduced renal function in elderly persons. Semin Nephrol 2009; 29:594-603; PMID:20006791; http://dx.doi.org/10.1016/j.semnephrol.2009.07.013.
139. Sebeková K, Somoza V. Dietary advanced glycation endproducts (AGEs) and their health effects - PRO. Mol Nutr Food Res 2007; 51:1079-84; PMID:17854003; http://dx.doi.org/10.1002/mnfr.200700035.
140. Yamagishi S, Ueda S, Okuda S. Food-derived advanced glycation end products (AGEs): a novel therapeutic target for various disorders. Curr Pharm Des 2007; 13:2832-6; PMID:17897026; http://dx.doi.org/10.2174/ 138161207781757051.
141. Vlassara H, Striker GE. AGE restriction in diabetes mellitus: a paradigm shift. Nat Rev Endocrinol 2011; 7:526-39; PMID:21610689; http://dx.doi.org/10. 1038/nrendo.2011.74.
142. Peppa M, Brem H, Ehrlich P, Zhang JG, Cai W, Li Z, et al. Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice. Diabetes 2003; 52:2805-13; PMID:14578300; http://dx.doi.org/10.2337/diabetes.52.11.2805.
143. Lyons TJ, Bailie KE, Dyer DG, Dunn JA, Baynes JW. Decrease in skin collagen glycation with improved glycemic control in patients with insulin-dependent diabetes mellitus. J Clin Invest 1991; 87:1910-5; PMID:1904067; http://dx.doi.org/10.1172/JCI115216.
144. Monnier VM, Bautista O, Kenny D, Sell DR, Fogarty J, Dahms W, et al.; DCCT Skin Collagen Ancillary Study Group. Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial. Diabetes 1999; 48:870-80; PMID:10102706; http://dx.doi.org/10.2337/diabetes.48.4.870.
145. Hudson BI, Bucciarelli LG, Wendt T, Sakaguchi T, Lalla E, Qu W, et al. Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders. Arch Biochem Biophys 2003; 419:80-8; PMID:14568011; http://dx.doi.org/10.1016/j. abb.2003.08.030.
146. Yan SF, Ramasamy R, Schmidt AM. Soluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and aging. Biochem Pharmacol 2010; 79:1379-86; PMID:20096667; http://dx.doi.org/10.1016/j.bcp.2010.01.013.
147. Goova MT, Li J, Kislinger T, Qu W, Lu Y, Bucciarelli LG, et al. Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am J Pathol 2001; 159:513-25; PMID:11485910; http://dx.doi.org/10.1016/S0002-9440(10)61723-3.
148. Babizhayev MA, Nikolayev GM, Nikolayeva JG, Yegorov YE. Biologic activities of molecular chaperones and pharmacologic chaperone imidazole-containing dipeptide-based compounds: natural skin care help and the ultimate challenge: implication for adaptive responses in the skin. Am J Ther 2012; 19:e69-89; PMID:20861720; http://dx.doi.org/10.1097/MJT.0b013e3181e71fb7.
149. Babizhayev MA, Yegorov YE. Therapeutic uses of drug-carrier systems for imidazole-containing dipeptide compounds that act as pharmacological chaperones and have significant impact on the treatment of chronic diseases associated with increased oxidative stress and the formation of advanced glycation end products. Crit Rev Ther Drug Carrier Syst 2010; 27:85-154; PMID:20486899; http://dx.doi.org/10.1615/CritRevTherDrugCarrierSyst.v27.i2.10.
150. Babizhayev MA, Deyev AI, Savel'yeva EL, Lankin VZ, Yegorov YE. Skin beautification with oral non-hydrolized versions of carnosine and carcinine: Effective therapeutic management and cosmetic skincare solutions against oxidative glycation and free-radical production as a causal mechanism of diabetic complications and skin aging. J Dermatolog Treat 2011; In press; PMID:21756141; http://dx.doi.org/10.3109/09546634.2010.521812.